Elicio Therapeutics, Inc.ELTXNASDAQ
LOADING
|||
Switch Symbol:

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating
Buy
1 analyst·Low coverage
100%
Rating Distribution
Strong Buy
00%
Buy
1100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Current price is 82% above analyst consensus — significant downside expected.

Bear Case
$1.50
-82%
Consensus
$1.50
-82%
Bull Case
$1.50
+-82%
Price Range1 analyst
Low
Consensus
High
$1.50
$1.50
Current Target
Current Price
$8.11
Above Target
$6.61

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jun 30, 2022Stifel Nicolaus
Angion Biomedica downgraded to Hold from Buy at Stifel
Target:$1.50
-12.3%from $1.71